Annual gross profit:
$2.32B+$473.90M(+25.65%)Summary
- As of today (April 16, 2025), NBIX annual gross profit is $2.32 billion, with the most recent change of +$473.90 million (+25.65%) on December 1, 2024.
- During the last 3 years, NBIX annual gross profit has risen by +$1.20 billion (+107.41%).
- NBIX annual gross profit is now at all-time high.
Performance
NBIX Gross profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly gross profit:
$618.40M+$4.30M(+0.70%)Summary
- As of today (April 16, 2025), NBIX quarterly gross profit is $618.40 million, with the most recent change of +$4.30 million (+0.70%) on December 1, 2024.
- Over the past year, NBIX quarterly gross profit has increased by +$110.60 million (+21.78%).
- NBIX quarterly gross profit is now at all-time high.
Performance
NBIX quarterly gross profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM gross profit:
$2.32B+$111.70M(+5.06%)Summary
- As of today (April 16, 2025), NBIX TTM gross profit is $2.32 billion, with the most recent change of +$111.70 million (+5.06%) on December 1, 2024.
- Over the past year, NBIX TTM gross profit has increased by +$378.00 million (+19.45%).
- NBIX TTM gross profit is now at all-time high.
Performance
NBIX TTM gross profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Gross profit Formula
Gross Profit = Revenue − Cost Of Goods Sold
NBIX Gross profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +25.6% | +21.8% | +19.4% |
| 3 y3 years | +107.4% | +21.8% | +19.4% |
| 5 y5 years | +197.3% | +21.8% | +19.4% |
NBIX Gross profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +107.4% | at high | +102.1% | at high | +94.8% |
| 5 y | 5-year | at high | +197.3% | at high | +164.6% | at high | +164.3% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% | at high | >+9999.0% |
Neurocrine Biosciences Gross profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $2.32B(+25.7%) | $618.40M(+0.7%) | $2.32B(+5.1%) |
| Sep 2024 | - | $614.10M(+5.7%) | $2.21B(+6.1%) |
| Jun 2024 | - | $581.00M(+14.4%) | $2.08B(+7.2%) |
| Mar 2024 | - | $507.80M(+0.2%) | $1.94B(+5.2%) |
| Dec 2023 | $1.85B(+26.1%) | $506.70M(+3.9%) | $1.85B(+5.9%) |
| Sep 2023 | - | $487.60M(+10.5%) | $1.75B(+6.5%) |
| Jun 2023 | - | $441.20M(+7.1%) | $1.64B(+4.3%) |
| Mar 2023 | - | $411.90M(+1.9%) | $1.57B(+7.2%) |
| Dec 2022 | $1.47B(+30.9%) | $404.30M(+5.9%) | $1.47B(+7.0%) |
| Sep 2022 | - | $381.80M(+2.2%) | $1.37B(+7.0%) |
| Jun 2022 | - | $373.40M(+22.0%) | $1.28B(+7.4%) |
| Mar 2022 | - | $306.00M(-0.6%) | $1.19B(+6.5%) |
| Dec 2021 | $1.12B(+8.1%) | $307.90M(+5.5%) | $1.12B(+6.0%) |
| Sep 2021 | - | $291.80M(+2.1%) | $1.06B(+3.5%) |
| Jun 2021 | - | $285.80M(+22.3%) | $1.02B(-1.4%) |
| Mar 2021 | - | $233.70M(-4.6%) | $1.03B(-0.1%) |
| Dec 2020 | $1.04B(+32.7%) | $245.00M(-4.2%) | $1.04B(+0.3%) |
| Sep 2020 | - | $255.80M(-14.7%) | $1.03B(+3.6%) |
| Jun 2020 | - | $300.00M(+27.7%) | $996.50M(+13.4%) |
| Mar 2020 | - | $235.00M(-2.7%) | $878.40M(+12.5%) |
| Dec 2019 | $780.70M(+74.9%) | $241.60M(+9.9%) | $780.70M(+16.7%) |
| Sep 2019 | - | $219.90M(+20.9%) | $669.01M(+11.6%) |
| Jun 2019 | - | $181.90M(+32.5%) | $599.31M(+16.7%) |
| Mar 2019 | - | $137.30M(+5.7%) | $513.46M(+15.0%) |
| Dec 2018 | $446.30M(+178.3%) | $129.91M(-13.5%) | $446.30M(+8.8%) |
| Sep 2018 | - | $150.21M(+56.4%) | $410.15M(+28.1%) |
| Jun 2018 | - | $96.05M(+36.9%) | $320.29M(+38.9%) |
| Mar 2018 | - | $70.14M(-25.2%) | $230.51M(+43.7%) |
| Dec 2017 | $160.37M(+969.1%) | $93.76M(+55.4%) | $160.37M(+140.7%) |
| Sep 2017 | - | $60.34M(+861.8%) | $66.61M(+961.8%) |
| Jun 2017 | - | $6.27M(>+9900.0%) | $6.27M(>+9900.0%) |
| Mar 2017 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2016 | $15.00M | $0.00(0.0%) | $0.00(0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2016 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2016 | - | $0.00(-100.0%) | $0.00(-100.0%) |
| Dec 2015 | $19.77M(+569.5%) | - | - |
| Sep 2011 | - | $41.63M(+242.5%) | $66.30M(+69.5%) |
| Jun 2011 | - | $12.16M(-2.8%) | $39.12M(+23.8%) |
| Mar 2011 | - | $12.51M(-13.4%) | $31.60M(+53.5%) |
| Sep 2010 | - | $14.45M(+211.2%) | $20.58M(+199.7%) |
| Jun 2010 | - | $4.64M(+516.6%) | $6.87M(+132.1%) |
| Mar 2010 | - | $753.00K(+1.8%) | $2.96M(+0.2%) |
| Dec 2009 | $2.95M(-25.7%) | $740.00K(+1.0%) | $2.95M(+33.4%) |
| Sep 2009 | - | $733.00K(0.0%) | $2.21M(+49.5%) |
| Jun 2009 | - | $733.00K(-1.9%) | $1.48M(+98.1%) |
| Mar 2009 | - | $747.00K(-81.9%) | $747.00K(-95.5%) |
| Dec 2008 | $3.98M(-76.3%) | - | - |
| Dec 2000 | $16.79M(-11.2%) | $4.13M(-29.9%) | $16.79M(-3.9%) |
| Sep 2000 | - | $5.89M(+69.2%) | $17.46M(+1.1%) |
| Jun 2000 | - | $3.48M(+5.5%) | $17.27M(-4.1%) |
| Mar 2000 | - | $3.30M(-31.3%) | $18.01M(-4.8%) |
| Dec 1999 | $18.90M(+6.8%) | $4.80M(-15.8%) | $18.91M(-0.5%) |
| Sep 1999 | - | $5.70M(+35.4%) | $19.01M(+0.5%) |
| Jun 1999 | - | $4.21M(+0.2%) | $18.91M(+8.7%) |
| Mar 1999 | - | $4.20M(-14.3%) | $17.40M(-1.7%) |
| Dec 1998 | $17.70M(-35.4%) | $4.90M(-12.5%) | $17.70M(-8.8%) |
| Sep 1998 | - | $5.60M(+107.4%) | $19.40M(-4.4%) |
| Jun 1998 | - | $2.70M(-40.0%) | $20.30M(-10.6%) |
| Mar 1998 | - | $4.50M(-31.8%) | $22.70M(-16.8%) |
| Dec 1997 | $27.40M(+35.6%) | $6.60M(+1.5%) | $27.30M(-9.9%) |
| Sep 1997 | - | $6.50M(+27.5%) | $30.30M(+15.2%) |
| Jun 1997 | - | $5.10M(-44.0%) | $26.30M(-2.2%) |
| Mar 1997 | - | $9.10M(-5.2%) | $26.90M(+33.2%) |
| Dec 1996 | $20.20M | $9.60M(+284.0%) | $20.20M(+90.6%) |
| Sep 1996 | - | $2.50M(-56.1%) | $10.60M(+30.9%) |
| Jun 1996 | - | $5.70M(+137.5%) | $8.10M(+237.5%) |
| Mar 1996 | - | $2.40M | $2.40M |
FAQ
- What is Neurocrine Biosciences annual gross profit?
- What is the all time high annual gross profit for Neurocrine Biosciences?
- What is Neurocrine Biosciences annual gross profit year-on-year change?
- What is Neurocrine Biosciences quarterly gross profit?
- What is the all time high quarterly gross profit for Neurocrine Biosciences?
- What is Neurocrine Biosciences quarterly gross profit year-on-year change?
- What is Neurocrine Biosciences TTM gross profit?
- What is the all time high TTM gross profit for Neurocrine Biosciences?
- What is Neurocrine Biosciences TTM gross profit year-on-year change?
What is Neurocrine Biosciences annual gross profit?
The current annual gross profit of NBIX is $2.32B
What is the all time high annual gross profit for Neurocrine Biosciences?
Neurocrine Biosciences all-time high annual gross profit is $2.32B
What is Neurocrine Biosciences annual gross profit year-on-year change?
Over the past year, NBIX annual gross profit has changed by +$473.90M (+25.65%)
What is Neurocrine Biosciences quarterly gross profit?
The current quarterly gross profit of NBIX is $618.40M
What is the all time high quarterly gross profit for Neurocrine Biosciences?
Neurocrine Biosciences all-time high quarterly gross profit is $618.40M
What is Neurocrine Biosciences quarterly gross profit year-on-year change?
Over the past year, NBIX quarterly gross profit has changed by +$110.60M (+21.78%)
What is Neurocrine Biosciences TTM gross profit?
The current TTM gross profit of NBIX is $2.32B
What is the all time high TTM gross profit for Neurocrine Biosciences?
Neurocrine Biosciences all-time high TTM gross profit is $2.32B
What is Neurocrine Biosciences TTM gross profit year-on-year change?
Over the past year, NBIX TTM gross profit has changed by +$378.00M (+19.45%)